GPT-4 gives ‘a mild uplift’ to creating a biochemical weapon Source Cluster: The Register Source Node: 1943585Time Stamp: Feb 1, 2024
Soligenix, Inc. CEO is Featured in an Interview with SmallCaps Daily Source Cluster: ACN Newswire Source Node: 1853758Time Stamp: Jun 29, 2023
Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024 Source Cluster: JCN Newswire Source Node: 1786807Time Stamp: Jan 12, 2023
CEPI Partners with Japan’s NEC Group to Develop Artificial Intelligence-designed Broadly Protective Betacoronavirus Vaccine Source Cluster: JCN Newswire Source Node: 1254021Time Stamp: Apr 8, 2022
Moderna Will Develop mRNA Vaccines for 15 of the World’s Worst Diseases Source Cluster: Singularity Hub Source Node: 1211706Time Stamp: Mar 10, 2022
3 Reasons Dogecoin Succeeded Where Others Failed Source Cluster: Coin Rivet Source Node: 1194831Time Stamp: Mar 2, 2022
The Vaccine Investment Hypothesis, and What’s Next (AZN, JNJ, DYAI, BNTX) Source Cluster: OTC PR Wire Source Node: 896626Time Stamp: Jun 2, 2021